NEUPERT PETER M 4

What Happened

• Peter M. Neupert, a director of Labcorp Holdings Inc. (LH), received an award of 773 restricted stock units (RSUs) on February 10, 2026. The grant is reported as a derivative award at a reported price of $0.00. The RSUs are the contingent right to receive one share of Labcorp common stock per unit and will vest fully on February 10, 2027.

Key Details

• Transaction date: February 10, 2026; Filing date: February 12, 2026 (filed within the 2-business-day Form 4 deadline).
• Award size and price: 773 RSUs @ $0.00 (derivative award; no cash purchase).
• Shares/units held after transaction: 773 RSUs (aggregate held by the reporting person, per filing).
• Footnotes: F1 — each RSU converts to one share when settled; F2 — full vesting on Feb 10, 2027; F3 — number shown is the reporting person's aggregate RSUs.
• Remarks: Exhibit 24 (Power of Attorney) included.

Context

• This is a compensation-related RSU grant, not an open-market purchase or sale. RSUs do not convert to actual shares until they vest and are typically subject to tax withholding and company vesting conditions (no sale or cashless exercise was reported). Such awards are routine for executives/directors and do not by themselves signal a buy or sell decision.